E.g., 11/30/2022
E.g., 11/30/2022
Titlesort ascending Category Credit Event date Price
Economics of Healthcare: Understanding Physician Compensation Webcast (2022) $249.00 Following a general introduction to the economics of clinical practice and various practice models (e.g. private group practice, academic and non-academic health system employment, and private equity funded), the specifics of various compensation arrangements, bonuses, benefits and other aspects of total compensation will be reviewed in detail. Indirect aspects of compensation models including topics such as call, funding and use of advanced practitioners in a practice, and expense structures will also be discussed.
Diversity, Equity and Inclusion (DEI) in Urology Series (2022) $0.00 The American Urological Association (AUA) is proposing to create a series of educational activities that aim to address Diversity, Equity and Inclusion (DEI) in Urology. The AUA recognizes that the strength of any community is rooted in diversity and is committed to leading the way in advancing DEI within urology.Diversity, Equity and Inclusion (DEI) in Urology is comprised of multiple educational formats, including a live (in-person and virtual) course, on-demand webcast and AUAUniversity podcast series. 
Diversity Equity and Inclusion in Urology: What Do We Need to Know Webcast (2022)
    • 2.00 AMA PRA Category 1 Credit™
    • 2.00 Non-Physician Participation
$0.00 The course will review the statistics of underrepresented minorities in urology and why Diversity, Equity and Inclusion (DEI) initiatives are necessary for the advancement of urology. We will define racism and educate participants on the different forms of racism. We will identify current tactics to increase the number of underrepresented minorities in urology.
Difficult Cases in High-Risk Bladder Cancer: An Evidence-Based Approach Webcast (2022)
    • 2.00 AMA PRA Category 1 Credit™
    • 2.00 Non-Physician Participation
$0.00 The course director will select 6 real cases from his own practice that represent challenging cases in bladder cancer and present them to his panelists. The panelists will review the available literature and formulate a treatment plan based upon the guidelines and published literature. The course director will then present the actual patient outcome and readdress the panelists with follow-up problems and questions to illustrate the many unique aspects of dealing with these patients.ACKNOWLEDGEMENTSSupport provided by independent educational grants from:
Diagnosis and Management of Localized, Locally Advanced and Advanced Kidney Cancer Webcast (2022)
    • 2.00 AMA PRA Category 1 Credit™
    • 2.00 Non-Physician Participation
$0.00 Kidney cancer is not a single disease; it is made up of several different types of cancer, each with a different histology, a different clinical course, responding differently to therapy and caused by different genes. After completing this course, attendees be able to describe the different types of kidney cancer and the genes that cause each. They will learn how to identify the different types of inherited versus sporadic forms of kidney cancer.
Cultural Barriers for Ethnic Minorities Podcast (2022)
    • 0.50 AMA PRA Category 1 Credit™
    • 0.50 Non-Physician Participation
$0.00 The American Urological Association (AUA) is proposing to create a series of educational activities that aim to address Diversity, Equity and Inclusion (DEI) in Urology. The AUA recognizes that the strength of any community is rooted in diversity and is committed to leading the way in advancing DEI within urology.Diversity, Equity and Inclusion (DEI) in Urology is comprised of multiple educational formats, including a live (in-person and virtual) course, on-demand webcast and AUAUniversity podcast series. 
Controversies, Confusion, and the Future of Urologic Post-Operative Opioid Prescribing Reduction Strategies (2022)
    • 0.75 AMA PRA Category 1 Credit™
    • 0.75 Non-Physician Participation
$0.00 This activity includes a multidisciplinary panel of experts discussing how urologists can reduce opioid prescribing, non-opioid multi-modal options, alternative therapies to pain management, managing opioid tolerant patients, and upcoming post-operative pain management opportunities. 
Contemporary Pharmacotherapy for OAB 2022: Monotherapy and Combined Pharmacotherapy to Optimize Treatment Webcast (2022)
    • 2.00 AMA PRA Category 1 Credit™
    • 2.00 Non-Physician Participation
$0.00 Much has been written and debated about drug treatment of overactive bladder (OAB) over the past 2 decades. Nevertheless, the field continues to evolve. OAB pharmacotherapy remains an area of active investigation, and innovation.
Conflict of Interest Disclosures $0.00 The mission of the AUA Office of Education is to provide quality, evidence-based continuing medical education that is independent and free of commercial bias to enhance the clinical competence and performance of urologists and the urologic care team.
Building a Primary Palliative Care Model for Urology Webcast (2021)
    • 2.00 AMA PRA Category 1 Credit™
    • 2.00 Non-Physician Participation
$0.00 Building a Primary Palliative Care Model for Urology Webcast (2021) discusses aspects of palliative care that benefit patients, the urologist’s role and their collaboration with palliative care clinicians including:
Bladder Cancer Treatment Dilemmas: The Cases You Face and What To Do about Them Webcast (2022)
    • 2.00 AMA PRA Category 1 Credit™
    • 2.00 Non-Physician Participation
$0.00 Update recent AUA, European Association of Urology (EAU), and National Comprehensive Cancer Network (NCCN®) Guidelines® for the quickly evolving field of bladder cancer. Case scenarios will outline important changes as well as concepts essential in providing evidence-based care.ACKNOWLEDGEMENTSSupport provided by independent educational grants from:AstraZenecaBristol Myers SquibbMerck & Co., Inc.Pfizer, Inc.
Big Data and 'Omics' Analysis in Urology (2020) $149.00 This course provides participants with an introduction to systems biology along with insights into the methods used to generate large datasets using ‘omics’ technologies, and the bioinformatics tools required for analysis. Despite the power of genomic, transcriptomic, and proteomic technologies, most researchers do not have the necessary computational expertise to analyze or interpret high content datasets unaided. Furthermore, many investigators are unaware of the unique challenges involved in experimental design as it pertains to systems-wide analyses.
Audio Playlist $0.00
Audio Playlist $0.00
AUA Virtual Coding Seminar Webcast (2020) $249.00  

Pages